Olfat Shaker

7.9k total citations
464 papers, 5.6k citations indexed

About

Olfat Shaker is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Olfat Shaker has authored 464 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Molecular Biology, 150 papers in Cancer Research and 77 papers in Epidemiology. Recurrent topics in Olfat Shaker's work include Cancer-related molecular mechanisms research (113 papers), MicroRNA in disease regulation (76 papers) and Circular RNAs in diseases (57 papers). Olfat Shaker is often cited by papers focused on Cancer-related molecular mechanisms research (113 papers), MicroRNA in disease regulation (76 papers) and Circular RNAs in diseases (57 papers). Olfat Shaker collaborates with scholars based in Egypt, Saudi Arabia and United States. Olfat Shaker's co-authors include Nermin Abdel Hamid Sadik, Noha A. Ghallab, Mahmoud A. Senousy, Tarek K. Motawi, Dalia Ahmed Bassiouny, Mohamed H.M. El-Komy, Tarek I. Ahmed, Amal El‐Shehaby, Noha A. El-Boghdady and Eman M. Elbaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Olfat Shaker

424 papers receiving 5.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Olfat Shaker	2.2k	1.8k	912	818	460	464	5.6k
Efstratios Patsouris	3.2k 1.5×	1.5k 0.8×	821 0.9×	1.1k 1.3×	345 0.8×	385	9.0k
Mark W. Lingen	2.8k 1.3×	1.2k 0.7×	479 0.5×	654 0.8×	169 0.4×	175	7.6k
Liang Tang	2.5k 1.1×	1.3k 0.7×	528 0.6×	557 0.7×	64 0.1×	220	6.0k
Tetsuya Yamamoto	1.6k 0.7×	757 0.4×	670 0.7×	579 0.7×	141 0.3×	329	6.4k
Xiang Cheng	2.5k 1.1×	1.0k 0.6×	812 0.9×	2.1k 2.6×	63 0.1×	226	6.6k
Corrado Rubini	2.4k 1.1×	997 0.6×	469 0.5×	391 0.5×	128 0.3×	261	6.2k
Francisco O′Valle	1.5k 0.7×	271 0.2×	478 0.5×	766 0.9×	108 0.2×	215	6.4k
Li Gao	1.3k 0.6×	435 0.2×	588 0.6×	702 0.9×	246 0.5×	134	4.0k
Hein W. Verspaget	3.1k 1.4×	1.7k 1.0×	1.4k 1.5×	1.6k 2.0×	99 0.2×	236	9.7k
Andrew Filer	1.9k 0.9×	667 0.4×	408 0.4×	2.5k 3.0×	111 0.2×	176	7.2k

Countries citing papers authored by Olfat Shaker

Since Specialization

Citations

This map shows the geographic impact of Olfat Shaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olfat Shaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olfat Shaker more than expected).

Fields of papers citing papers by Olfat Shaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olfat Shaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olfat Shaker. The network helps show where Olfat Shaker may publish in the future.

Co-authorship network of co-authors of Olfat Shaker

This figure shows the co-authorship network connecting the top 25 collaborators of Olfat Shaker. A scholar is included among the top collaborators of Olfat Shaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olfat Shaker. Olfat Shaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaker, Olfat, et al.. (2025). Integrated analysis of non‑coding RNAs (HOTAIR and miR‑130a) and their cross‑talk with TGF‑β1, SIRT1 and E‑cadherin as potential biomarkers in colorectal cancer. Oncology Letters. 29(3). 116–116. 1 indexed citations

Hegazy, Gehan A., et al.. (2025). Expression of lncRNA NEAT1, miR-21, and IL17 in Rheumatoid Arthritis Patients. Biologics. Volume 19. 201–211.

Shaker, Olfat, et al.. (2024). Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions. BMC Oral Health. 24(1). 834–834.

Shaker, Olfat, et al.. (2024). Regulatory role of the lncRNAs MIAT and PVT1 in Behçet’s disease through targeting miR-93-5p and miR-124-3p. Molecular Medicine. 30(1). 157–157. 1 indexed citations

Shaker, Olfat, et al.. (2024). Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis. Frontiers in Immunology. 15. 1449296–1449296. 2 indexed citations

Shaker, Olfat, et al.. (2024). Microribonucleic acid-9 (miRNA-9) as a potential diagnostic marker in Behҫet’s syndrome patients. The Egyptian Rheumatologist. 46(4). 190–193.

Taher, Heba, et al.. (2024). The possible anti-inflammatory effect of extra virgin olive oil with colchicine in treatment of resistant cases of familial Mediterranean fever in a cohort of pediatric Egyptian patients. SHILAP Revista de lepidopterología. 10(1). 2 indexed citations

Shaker, Olfat, et al.. (2023). Breast cancer risk is associated with the HULC rs7763881, MTMR3 rs12537 polymorphisms, and serum levels of HULC and MTMR3 in Egyptian patients. Molecular Biology Reports. 50(12). 10073–10081. 2 indexed citations

Alem, Shereen Abdel, et al.. (2023). The Interrelation Between Hypothyroidism and Non-alcoholic Fatty Liver Disease, a Cross-sectional Study. Journal of Clinical and Experimental Hepatology. 13(4). 638–648. 7 indexed citations

10.

Shaker, Olfat, et al.. (2023). The Role of lncRNAs in Stroke: MEG3 as a Promising Candidate. 0(0). 0–0. 1 indexed citations

11.

Shaker, Olfat, et al.. (2023). Association of lncRNA MEG3 Rs7158663 Polymorphism and Serum Expression with Colorectal Cancer in Egyptian Patients. 12(1). 102–111.

12.

Shaker, Olfat, et al.. (2023). Local gingival crevicular fluid, synovial fluid, and circulating levels of prolactin hormone in patients with moderately active rheumatoid arthritis and stage III and IV periodontitis before and after non-surgical periodontal treatment—a controlled trial. Clinical Oral Investigations. 27(6). 2813–2821. 2 indexed citations

13.

Shaker, Olfat, et al.. (2023). “Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study”. BMC Oral Health. 23(1). 994–994. 12 indexed citations

14.

Shaker, Olfat, et al.. (2023). MALAT1 as a potential salivary biomarker in oral squamous cell carcinoma through targeting miRNA‐124. Oral Diseases. 30(4). 2075–2083. 15 indexed citations

15.

Shaker, Olfat, et al.. (2022). Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study). Oral Diseases. 29(4). 1487–1494. 6 indexed citations

16.

Mahmoud, Rania H., et al.. (2022). The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus. PLoS ONE. 17(8). e0268176–e0268176. 9 indexed citations

17.

Shaker, Olfat, et al.. (2022). Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, miR-363 and miR-17. Scientific Reports. 12(1). 1249–1249. 17 indexed citations

18.

Hefzy, Enas M., et al.. (2021). miR-155 T/A (rs767649) and miR-146a A/G (rs57095329) single nucleotide polymorphisms as risk factors for chronic hepatitis B virus infection among Egyptian patients. PLoS ONE. 16(8). e0256724–e0256724. 2 indexed citations

19.

Talaat, Iman M., et al.. (2021). Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy. Pharmaceuticals. 14(7). 608–608. 13 indexed citations

20.

Lotfy, Mahmoud, et al.. (2020). MicroRNA-15a expression level and its target “c-Myb” expression in Hepatocellular carcinoma Among Chronic HCV Egyptian Patients. 6(2). 1–10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact